Eko Murmur Analysis Software (EMAS) vs LINQ II Insertable Cardiac Monitor
AI Verdict
Choose Eko Murmur Analysis Software (EMAS) if…
Choose Eko Murmur Analysis Software (EMAS) if you require an immediate, point-of-care AI-powered solution for detecting and differentiating heart murmurs during routine physical examinations. This tool is ideal for clinicians seeking real-time clinical decision support to identify potential heart and lung conditions in both adult and pediatric patients using a digital stethoscope, facilitating quick recording, analysis, and sharing of heart sound data for initial assessments.
View Eko Murmur Analysis Software (EMAS) →Choose LINQ II Insertable Cardiac Monitor if…
Choose the Medtronic LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous heart rhythm monitoring to diagnose infrequent or paroxysmal arrhythmias that may not be captured during intermittent evaluations. This device is best suited for extended surveillance, offering up to 4.5 years of monitoring with AI-enhanced accuracy and remote management capabilities, particularly when transient symptoms make diagnosis challenging with shorter-term methods.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Murmur Analysis Software (EMAS) | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. | Unknown |
| Deployment | Cloud-based, Mobile App | Subcutaneous implant with remote monitoring via mobile app or home communicator. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Murmur Analysis Software (EMAS)Eko Murmur Analysis Software (EMAS) offers a more straightforward and non-invasive user experience for clinicians, integrating with a digital stethoscope and accessed via a mobile app for immediate point-of-care use. In contrast, the LINQ II is an insertable device, requiring a surgical procedure for the patient, which presents a different and more involved form of interaction for both patient and clinician.
Clinical Value
LINQ II Insertable Cardiac MonitorWhile EMAS provides valuable clinical decision support for early murmur detection, the Medtronic LINQ II offers long-term, continuous heart rhythm monitoring for up to 4.5 years, which is critical for diagnosing intermittent or asymptomatic arrhythmias that might be missed by a single examination. Its AccuRhythmu2122 AI algorithms and innovative PVC detection provide a deeper, more sustained diagnostic capability for complex cardiac conditions.
Pricing & Value
Eko Murmur Analysis Software (EMAS)EMAS offers a transparent pricing model, including a free tier for basic AI analysis with the Eko App and clearly defined paid subscriptions for advanced features. This accessibility and transparency provide significant value. The LINQ II, conversely, uses an enterprise pricing model that is not publicly disclosed and typically negotiated with healthcare systems, lacking the same level of transparency and immediate accessibility.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic, as a long-established global medical device company, has a proven track record of deploying complex medical technologies within healthcare systems worldwide, with over 1 million patients having received a Medtronic ICM. The LINQ II's enterprise pricing model and target market of solo to large health systems, coupled with its hybrid deployment and HIPAA compliance, demonstrate robust enterprise readiness.
Innovation
LINQ II Insertable Cardiac MonitorThe LINQ II represents a significant innovation in continuous cardiac monitoring by combining an insertable device with AI-powered accuracy (AccuRhythmu2122 AI), remote programming capabilities, and an extended monitoring period of up to 4.5 years. While EMAS innovates by bringing AI to the traditional stethoscope, the LINQ II's integration of advanced AI with an implantable, long-term monitoring solution for arrhythmia detection is a more transformative innovation in patient care.
Support & Docs
LINQ II Insertable Cardiac MonitorWhile both companies offer support, Medtronic, as a large global medical device manufacturer with a long history, provides extensive resources including dedicated patient and clinician support, manuals, and guides for their complex implantable devices. The critical nature and complexity of an insertable cardiac monitor necessitate a highly robust and comprehensive support infrastructure, which Medtronic is well-equipped to provide.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Murmur Analysis Software (EMAS) | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Product Name | Eko Murmur Analysis Software (EMAS) | LINQ II Insertable Cardiac Monitor |
| Company | Eko Devices | Medtronic |
| Primary Function / Key AI Feature | FDA-cleared AI for murmur detection, differentiates innocent and structural heart murmurs, provides clinical decision support. | AccuRhythmu2122 AI algorithms for enhanced accuracy, long-term continuous heart rhythm monitoring, innovative PVC detection algorithm. |
| Target Patient Population | Adult and pediatric patients. | Pediatric indication (ages 2+). |
| Device Type / Integration | Integrates with Eko digital stethoscopes (CORE 500, DUO, CORE); mobile app for recording, playback, annotation. | Insertable Cardiac Monitor; MyCareLink Heartu2122 mobile app for data transmission. |
| Monitoring Duration | Not specified | Up to 4.5 years of continuous monitoring. |
Videos
Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and LINQ II Insertable Cardiac Monitor.